Symbicort

GPTKB entity

Statements (44)
Predicate Object
gptkbp:instanceOf gptkb:drug
gptkbp:activeIngredient gptkb:budesonide
gptkb:formoterol
gptkbp:approvedBy gptkb:FDA
gptkb:EMA
2000
gptkbp:ATCCode gptkb:R03AK07
gptkbp:brand gptkb:budesonide/formoterol
gptkbp:canBe adults
children over 6 years (varies by country)
gptkbp:commonBrandNames gptkb:Symbicort_Rapihaler
gptkb:Symbicort_Turbuhaler
gptkbp:compatibleWith acute asthma attacks
acute bronchospasm
gptkbp:contraindication hypersensitivity to budesonide
hypersensitivity to formoterol
gptkbp:drugClass gptkb:Corticosteroid
long-acting beta2-adrenergic agonist
gptkbp:form dry powder inhaler
metered-dose inhaler
inhaler
gptkbp:genericAvailable yes
https://www.w3.org/2000/01/rdf-schema#label Symbicort
gptkbp:inhalerColor red and white
gptkbp:legalStatus Rx-only
gptkbp:manufacturer gptkb:AstraZeneca
gptkbp:marketedIn gptkb:European_Union
gptkb:United_States
gptkbp:mechanismOfAction reduces inflammation and relaxes airway muscles
gptkbp:pregnancyCategory C (US)
gptkbp:prescribes maintenance treatment of COPD
maintenance treatment of asthma
gptkbp:prescriptionRequired available from AstraZeneca
gptkbp:prescriptionStatus prescription only
gptkbp:routeOfAdministration inhalation
gptkbp:sideEffect thrush
headache
increased heart rate
hoarseness
gptkbp:storage store at room temperature
gptkbp:usedFor asthma
chronic obstructive pulmonary disease
gptkbp:bfsParent gptkb:AstraZeneca
gptkbp:bfsLayer 5